SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

JP Morgan Initiates Coverage On ITeos Therapeutics with Overweight Rating, Announces Price Target of $40

JP Morgan analyst Anupam Rama initiates coverage on ITeos Therapeutics (NASDAQ:ITOS) with a Overweight rating and announces Price Target of $40.

Benzinga · 08/18/2020 11:04
JP Morgan analyst Anupam Rama initiates coverage on ITeos Therapeutics (NASDAQ: ITOS) with a Overweight rating and announces Price Target of $40.